22 Feb 2017
An experimental drug improved progression-free survival rates for patients with advanced midgut neuroendocrine tumours over a standard therapy, according to a recent global phase III clinical trial published in the New England Journal of Medicine.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024